Awardee OrganizationCAUCASECO SCIENTIFIC RESEARCH CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): The overall goal of this proposal is the establishment the "Centro Latino Americano de investigacion en Malaria - CLAIM" as a non-Amazonian malaria research center that would generate knowledge and provide technical and scientific support to governments of the partner countries as well as to organizations and health care institutions to further contribute to malaria elimination programs in the regions. CLAIM would initially bring together field sites from Colombia, Peru, Panama and Guatemala, and has plans to further include sites from Ecuador and Honduras and possibly other endemic countries of the Latin American (LA) and the Caribbean such as Haiti. CLAIM will be composed of multiple public and private research centers from the original partner countries, including centers and organizations depending from or associated to the Ministries of Health (MOH) from all participant countries. CLAIM has also involved consultants/collaborators from the Andean Health Organism and/or the US Centers for Disease Control for this ICEMR program. In addition, to the scientists from the partner countries, CLAIM will have the participation of prominent and experienced scientists from other endemic countries such as Ecuador and Brazil, as well as from United State (USA) and Europe. The ICEMR research activities have been divided into three closely inter-related projects as follows: Project 1 on Epidemiology will determine the ecological and epidemiological features in non-Amazonian regions; Project 2 on malaria transmission will address major gaps in our understanding of the ecology, behavior, vector potential, and control of Anopheles malaria vectors to guide the development and implementation of more effective integrated Vector Management (IVM) strategies, and Project 3 on malaria pathogenesis, that it will determine the clinical outcome of malaria infections and its correlation with the immunological status in communities living under different intensifies of malaria transmission in the study region. CLAIM would involve its epidemiology team to closely work with the National Malaria Control Program (NMCP) of all partner countries, to locate and track the "hot spots" and to assess the changing epidemiological conditions, identifying the malaria patterns and establishing linkages with environmental and anthropogenic factors or other determinants of malaria transmission. The study team will provide technical assistance for helping NMCPs improve surveillance operations, including quality control and assurance of data with respect to diagnostics. This ICEMR proposal includes training activities for selected junior scientists and groups of researchers/technicians. Special projects will be initiated by Year 3 of the program and will profit to redirect the program and/or involve other countries. A Data Management (DM) Core will coordinate all research protocol, DM, data analyses and publications. All CLAIM activities will be coordinated by Core A under responsibility of Caucaseco SRC. CLAIM will combine the multidisciplinary and integrated approach to enhance the research underpinnings for effective malaria elimination and possibly eradication. Data and findings generated by this Center are expected to provide input critical to inform future research design and evaluation of new interventions and control strategies.
RELEVANCE: This is a comprehensive project designed to establish an international Center of Excellence for Malaria Research in Latin America (CLAIM) composed of multiple public and private research centers from the endemic countries, the USA and Europe working jointly to find alternatives for malaria control. Results will facilitate malaria elimination in low malaria endemic settings.
PROJECT 1:
Title: Epidemiology of Malaria Transmission in Low to Moderate Settings of Latin America
Project Leader: Herrera, S.
PROJECT 1 DESCRIPTION (provided by applicant): The main objective of Project 1 is to evaluate the diversity of the ecology and parasite populations related to the epidemiology and clinical findings in order to establish a scientific framework that supports the development of new intervention strategies for malaria elimination in non-Amazonian areas of LA. This goal will be approached through the following specific aims: 1) Study the epidemiology of seasonal malaria and their relationship with parasite population diversity and 2) Identification of risk factors associated with malaria transmission in non-Amazonian areas of LA countries.
We hypothesize that circulating Plasmodium populations and their dynamics modulate the clinical manifestations and immune responses in the affected populations and that vector bionomics, parasite population diversity, host biology and behavior, household conditions, and local environmental conditions, act simultaneously to determine malaria transmission and risk of infection. The studies proposed for aim 1 are directed to determine the real prevalence and incidence of malaria by considering both symptomatic and asymptomatic individuals living in seasonal areas in LA.
This investigation includes community based cohort studies (prospective studies), active surveillance using temporal cross-sectional studies, and hospital based passive surveillance studies. The studies will be carried out in 7 endemic areas of Colombia, Peru, Panama and Guatemala, where a total of 21 sentinel sites will be studied. Studies will be carried out in three phases: 1) Our own census of the selected population from sentinel sites where inhabitants will be registered using a demographic questionnaire and houses coordinates using a GPS system; 2) thick smear and PCR for malaria diagnose in selected sentinels sites and random sampling in order to determine asymptomatic gametocytes carriers; 3) clinical follow-up and thick smear of asymptomatic at two sentinel sites (one in Colombia (Tierralta) and one in Peru (Sulluna). For aim 2 we will a) assess the conditions of antimalarial use in communities where malaria is endemic, including adherence, self-medication and prophylaxis; and (b) study the conditions of use of antimalarials in the public and private health institutions including the availability and suitability to care guides. In this ICEMR program, we will establish a network of sentinel sites that will be selected integrating bio-geographic criteria (vector and ecological conditions) and epidemiological information. Sentinel sites will provide baseline information on malaria ecology and epidemiology with the goal of characterizing parasite and vector populations resilient to control interventions. Such network will allow supporting current efforts directed to develop population models to quantify disease dynamics and malaria risk-maps to support MOH elimination activities.
RELEVANCE: Identify the relationship between environmental factors, parasite characteristics, household conditions and the malaria prevalence related to the epidemiology and clinical findings.
Public Health Relevance Statement
RELEVANCE: This is a comprehensive project designed to establish an international Center of Excellence for Malaria Research in Latin America (CLAIM) composed of multiple public and private research centers from the endemic countries, the USA and Europe working jointly to find alternatives for malaria control. Results will facilitate malaria elimination in low malaria endemic settings.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdherenceAffectAmericanAnopheles GenusAntimalarialsAreaBehaviorBiologyBionomicsBrazilCaribbean regionCaringCensusesCenters for Disease Control and Prevention (U.S.)CharacteristicsClinicalCohort StudiesColombiaCommunitiesCountryCross-Sectional StudiesDataData AnalysesDevelopmentDiagnosisDiagnosticDiseaseEcologyEcuadorEnvironmental Risk FactorEpidemiologyEuropeEvaluationGoalsGovernmentGuatemalaHaitiHealthHondurasHospitalsHot SpotHouseholdHousingImmune responseIncidenceIndividualInfectionInstitutionInterventionInvestigationKnowledgeLatin AmericaLatinoLifeMalariaMapsModelingOrganismOutcomePanamaParasitesParticipantPathogenesisPatternPeruPhasePlasmodiumPopulationPrevalenceProphylactic treatmentProspective StudiesProtocols documentationPublicationsQuality ControlQuestionnairesResearchResearch ActivityResearch PersonnelRiskRisk FactorsSamplingScientistSelf MedicationSentinelSiteSystemThickTraining ActivityUnited StatesWorkanthropogenesisbaseclinical epidemiologycommunity livingdata managementdesignepidemiology studyexperiencefollow-uphealth care service organizationimmunological statusimprovedinternational centermultidisciplinaryoperationprogramsquality assurancesurveillance studytransmission processvectorvector management strategies
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
881960108
UEI
RBVYEZXND859
Project Start Date
01-July-2010
Project End Date
30-June-2017
Budget Start Date
01-July-2013
Budget End Date
30-June-2014
Project Funding Information for 2013
Total Funding
$1,669,320
Direct Costs
$1,812,475
Indirect Costs
$144,997
Year
Funding IC
FY Total Cost by IC
2013
National Institute of Allergy and Infectious Diseases
$1,669,320
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 4U19AI089702-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 4U19AI089702-04
Patents
No Patents information available for 4U19AI089702-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 4U19AI089702-04
Clinical Studies
No Clinical Studies information available for 4U19AI089702-04
News and More
Related News Releases
No news release information available for 4U19AI089702-04
History
No Historical information available for 4U19AI089702-04
Similar Projects
No Similar Projects information available for 4U19AI089702-04